CD19 and acute lymphoblastic leukemia: This enrichment was not observed when comparing isogenic CD19 wild-type (WT) or knockout (KO) B-ALL cell lines (Supplementary Fig. 2C), suggesting that the sole loss of CD19 expression does not alter the developmental profile of B-ALL cells.